| VAV2 |
VAV2: Uncharacterized protein VAV2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.535 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| IGHM |
IPI00645352 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.535 |
Evidence |
|
| IGHM |
IPI00645352 |
IGHE |
IGHE: Ig epsilon chain C region |
0.535 |
Evidence |
|
| IGHM |
IPI00645352 |
IGHG1 |
IPI00645627 |
0.535 |
Evidence |
|
| IGHM |
IPI00645352 |
IGHA2 |
IGHA2: Ig alpha-2 chain C region |
0.535 |
Evidence |
|
| IGHM |
IPI00645352 |
IGHD |
IPI00549398 |
0.535 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
FLT4 |
VEGFR3 long form |
0.535 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.535 |
Evidence |
|
| HLA-A |
IPI00719058 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.535 |
Evidence |
|
| HLA-A |
IPI00719058 |
IGHE |
IGHE: Ig epsilon chain C region |
0.535 |
Evidence |
|
| HLA-A |
IPI00719058 |
IGHG1 |
IPI00645627 |
0.535 |
Evidence |
|
| HLA-A |
IPI00719058 |
IGHA2 |
IGHA2: Ig alpha-2 chain C region |
0.535 |
Evidence |
|
| HLA-A |
IPI00719058 |
IGHD |
IPI00549398 |
0.535 |
Evidence |
|
| HLA-A |
IPI00719058 |
IGHM |
IPI00645352 |
0.535 |
Evidence |
|
| HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
IGHE |
IGHE: Ig epsilon chain C region |
0.535 |
Evidence |
|
| HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
IGHG1 |
IPI00645627 |
0.535 |
Evidence |
|
| HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
IGHA2 |
IGHA2: Ig alpha-2 chain C region |
0.535 |
Evidence |
|
| HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
IGHD |
IPI00549398 |
0.535 |
Evidence |
|
| HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
IGHM |
IPI00645352 |
0.535 |
Evidence |
|
| HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
HLA-A |
IPI00719058 |
0.535 |
Evidence |
|
| BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
FLT4 |
VEGFR3 long form |
0.535 |
Evidence |
|